HEMODYNAMIC EFFECTS AND PLASMA CONCENTRATIONS OF LABETALOL DURING LONG-TERM TREATMENT OF ESSENTIAL HYPERTENSION

被引:43
作者
LUNDJOHANSEN, P [1 ]
BAKKE, OM [1 ]
机构
[1] UNIV BERGEN,SCH MED,CLIN PHARMACOL UNIT,CLIN BIOCHEM LAB,N-5014 BERGEN,NORWAY
关键词
D O I
10.1111/j.1365-2125.1979.tb00917.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:169 / 174
页数:6
相关论文
共 18 条
[1]  
BOLLI P, 1976, BRIT J CLIN PHARMACO, V3, P765
[2]  
BRITTAIN RT, 1976, BRIT J CLIN PHARMACO, V3, P681
[3]  
DARGIE HJ, 1976, BRIT J CLIN PHARMACO, V3, P751
[4]  
EDWARDS RC, 1976, BRIT J CLIN PHARMACO, V3, P733
[5]  
JOEKES AM, 1976, BRIT J CLIN PHARMACO, V3, P789
[6]  
KANE J, 1976, BRIT J CLIN PHARMACO, V3, P737
[7]  
KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P729
[8]  
KOCH G, 1976, BRIT J CLIN PHARMACO, V3, P725
[9]   HEMODYNAMIC LONG-TERM EFFECTS OF A NEW BETA-ADRENOCEPTOR BLOCKING DRUG, ATENOLOL (ICI 66082), IN ESSENTIAL HYPERTENSION [J].
LUNDJOHANSEN, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (03) :445-451
[10]   HEMODYNAMIC LONG-TERM EFFECTS OF PRAZOSIN PLUS TOLAMOLOL IN ESSENTIAL HYPERTENSION [J].
LUNDJOHANSEN, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) :141-145